Monoclonal B-cell lymphocytosis

From WikiMD's WELLNESSPEDIA


Monoclonal B-cell lymphocytosis
Synonyms MBL
Pronounce N/A
Specialty N/A
Symptoms Usually asymptomatic
Complications May progress to chronic lymphocytic leukemia
Onset Typically in older adults
Duration Indefinite
Types N/A
Causes Unknown
Risks Age, family history of hematologic malignancies
Diagnosis Flow cytometry
Differential diagnosis Chronic lymphocytic leukemia, Non-Hodgkin lymphoma
Prevention N/A
Treatment Observation
Medication N/A
Prognosis Generally good, but requires monitoring
Frequency Common in older adults
Deaths N/A


Monoclonal B-cell lymphocytosis (MBL) is a condition characterized by the presence of abnormal B cells in the blood. It is not a disease, but rather a laboratory finding that is often discovered incidentally during routine blood tests. MBL is considered a precursor state to certain types of lymphoma, particularly chronic lymphocytic leukemia (CLL).

Definition[edit]

Monoclonal B-cell lymphocytosis is defined by the presence of fewer than 5,000 monoclonal B-cells per microliter of blood, with no other signs or symptoms of lymphoproliferative disorders. The B-cells are monoclonal, meaning they are all identical clones of a single original cell.

Types[edit]

There are two types of MBL: 'low-count' and 'high-count'. Low-count MBL is more common and is usually not associated with progression to CLL. High-count MBL, on the other hand, has a higher risk of progression to CLL, although this risk is still relatively low.

Risk Factors[edit]

The risk factors for developing MBL include age, with the condition being more common in older adults, and a family history of CLL or other lymphoproliferative disorders.

Diagnosis[edit]

MBL is usually discovered incidentally during routine blood tests. If MBL is suspected, a flow cytometry test can be used to confirm the diagnosis. This test can identify the abnormal B-cells and determine whether they are monoclonal.

Treatment[edit]

As MBL is not a disease, it does not require treatment. However, individuals with high-count MBL may be monitored closely for signs of progression to CLL.

See Also[edit]

Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Monoclonal_B-cell_lymphocytosis&oldid=6542325"